These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37811936)
1. The interaction of human immunodeficiency virus-1 and human endogenous retroviruses in patients (primary cell cultures) and cell line models. Mantovani F; Kitsou K; Paraskevis D; Lagiou P; Magiorkinis G Microbiol Spectr; 2023 Dec; 11(6):e0137923. PubMed ID: 37811936 [TBL] [Abstract][Full Text] [Related]
2. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes. Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457 [TBL] [Abstract][Full Text] [Related]
3. HIV-1 Infection of Primary CD4 Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production. Bhardwaj N; Maldarelli F; Mellors J; Coffin JM J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891 [TBL] [Abstract][Full Text] [Related]
5. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection. Vincendeau M; Göttesdorfer I; Schreml JM; Wetie AG; Mayer J; Greenwood AD; Helfer M; Kramer S; Seifarth W; Hadian K; Brack-Werner R; Leib-Mösch C Retrovirology; 2015 Mar; 12():27. PubMed ID: 25886562 [TBL] [Abstract][Full Text] [Related]
6. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. Gonzalez-Hernandez MJ; Swanson MD; Contreras-Galindo R; Cookinham S; King SR; Noel RJ; Kaplan MH; Markovitz DM J Virol; 2012 Aug; 86(15):7790-805. PubMed ID: 22593154 [TBL] [Abstract][Full Text] [Related]
7. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938 [TBL] [Abstract][Full Text] [Related]
8. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309 [TBL] [Abstract][Full Text] [Related]
9. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. Contreras-Galindo R; López P; Vélez R; Yamamura Y AIDS Res Hum Retroviruses; 2007 Jan; 23(1):116-22. PubMed ID: 17263641 [TBL] [Abstract][Full Text] [Related]
11. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267 [TBL] [Abstract][Full Text] [Related]
12. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus? Morandi E; Tanasescu R; Tarlinton RE; Constantin-Teodosiu D; Gran B Front Immunol; 2018; 9():3092. PubMed ID: 30740110 [TBL] [Abstract][Full Text] [Related]
13. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein. Gonzalez-Hernandez MJ; Cavalcoli JD; Sartor MA; Contreras-Galindo R; Meng F; Dai M; Dube D; Saha AK; Gitlin SD; Omenn GS; Kaplan MH; Markovitz DM J Virol; 2014 Aug; 88(16):8924-35. PubMed ID: 24872592 [TBL] [Abstract][Full Text] [Related]
15. Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1. Monde K; Contreras-Galindo R; Kaplan MH; Markovitz DM; Ono A J Virol; 2012 Oct; 86(20):11194-208. PubMed ID: 22855497 [TBL] [Abstract][Full Text] [Related]
16. HIV infection and HERV expression: a review. van der Kuyl AC Retrovirology; 2012 Jan; 9():6. PubMed ID: 22248111 [TBL] [Abstract][Full Text] [Related]
17. Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS. Bhat RK; Rudnick W; Antony JM; Maingat F; Ellestad KK; Wheatley BM; Tönjes RR; Power C PLoS One; 2014; 9(7):e97984. PubMed ID: 24988390 [TBL] [Abstract][Full Text] [Related]
18. Human endogenous retroviruses in neurologic disease. Christensen T APMIS; 2016; 124(1-2):116-26. PubMed ID: 26818266 [TBL] [Abstract][Full Text] [Related]
19. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118 [TBL] [Abstract][Full Text] [Related]
20. Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency. Hurst T; Pace M; Katzourakis A; Phillips R; Klenerman P; Frater J; Magiorkinis G Retrovirology; 2016 Feb; 13():10. PubMed ID: 26852322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]